Crossmark

Melancholic features (DSM-IV) predict but do not moderate response to antidepressants in major depression: an individual participant data meta-analysis of 1219 patients

Crossref DOI link: https://doi.org/10.1007/s00406-020-01173-4

Published Online: 2020-07-26

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Imai, Hissei https://orcid.org/0000-0003-3656-5188
Noma, Hisashi

Furukawa, Toshi A.
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP17dk0307072)
License Information

Text and Data Mining valid from 2020-07-26

Version of Record valid from 2020-07-26
More Information

Article History

Received: 8 November 2019

Accepted: 22 July 2020

First Online: 26 July 2020

Compliance with ethical standards

:

: HI received the lecture fee from Tanabe-Mitsubishi pharma and Kyowa pharmaceutical industry outside the submitted work. TAF. reports personal fees from Meiji, Mitsubishi-Tanabe, MSD and Pfizer and a grant from Mitsubishi-Tanabe, outside the submitted work; T.A.F. has a patent 2018-177688 pending. H.N. has received lecture fees from Boehringer Ingelheim, ASKA and Kyowa Hakko Kirin, and research support from Kyowa Hakko Kirin and GSK, outside the submitted work.

Document is current

Any future updates will be listed below